Fenofibrate increases amount of sulfatide which may be beneficial against Covid-19

KarstenBuschard

https://doi.org/10.1016/j.mehy.2020.110127

Abstract

Fenofibrate, which is a PPAR-alfpha agonist, increases the level of sulfatide. In this letter we hypothesize on the background of various findings that this is beneficial against COVID-19. Fenofibrate has been used for decades against hypercholesterolemia and has no serious side effects. Therefore, a trial giving fenofibrate to patients with corona virus infection is recommended.

Download PDF

https://www.sciencedirect.com/science/article/pii/S0306987720322477